New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found large buildups of virus-targeting immune cells in the nervous ...

Problems with homelessness and open-air drug use have been widely broadcast, but many visitors this week said they found the city surprisingly pleasant.

Four people have died and three others have required a liver transplants after eating the death cap mushroom that is proliferating in California following a rainy winter.

Alzheimer’s disease is often discussed in terms of new drugs, scientific breakthroughs, and high treatment costs. But for ...

Advancements in corneal collagen cross-linking have significantly reduced the number of children who require a corneal ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...

Dementia care isn't just about new drugs, said the author of a cost-effectiveness study comparing collaborative care, Leqembi ...

The new workflow was adapted from an enzymatic DNA tagging technology, DNA-TAG, previously developed in the Devaraj lab. In ...

Blockbuster movies are less likely to portray smokers than they have in the past, according to a new study. What's more, this decline in on-screen smoking may have occurred in tandem with a drop in ...

Connor O'Brien, MD, provides an insight into awareness of dextrocardia and what clinicians can consider in the management of this population.

Explore how Epstein-Barr may link to multiple sclerosis, affecting nearly one million people in the United States.